Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

     
  (Mark One)
(X)
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 26, 2004

OR

     
(  )
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to

Commission File Number 000-17157

NOVELLUS SYSTEMS, INC.

(Exact name of Registrant as specified in its charter)
     
California
(State or other jurisdiction of
incorporation of organization)
  77-0024666
(I.R.S. Employer Identification
Number)

4000 North First Street, San Jose, California 95134
(Address of principal executive offices including zip code)

(408) 943-9700
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES (X) NO (  )

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

YES (X) NO (  )

As of July 29, 2004, 142,773,205 shares of the Registrant’s common stock, no par value, were issued and outstanding.

 


NOVELLUS SYSTEMS, INC.
FORM 10-Q
QUARTER ENDED JUNE 26, 2004

TABLE OF CONTENTS

         
    Page
       
       
    3  
    4  
    5  
    6  
    14  
    25  
    25  
       
    27  
    28  
    28  
    29  
    30  
 EXHIBIT 31.1
 EXHIBIT 31.2
 EXHIBIT 32.1
 EXHIBIT 32.2

2


Table of Contents

PART I: FINANCIAL INFORMATION

ITEM 1: CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)

                                 
    Three Months Ended
  Six Months Ended
    June 26, 2004
  June 28, 2003
  June 26, 2004
June 28, 2003
Net sales
  $ 338,219     $ 239,050     $ 601,081     $ 477,460  
Cost of sales
    168,539       133,728       306,796       262,324  
 
   
 
     
 
     
 
     
 
 
Gross profit
    169,680       105,322       294,285       215,136  
Operating expenses:
                               
Selling, general and administrative
    47,225       44,444       89,628       87,075  
Research and development
    63,471       56,509       122,428       113,515  
Acquired in-process research and development
    6,124             6,124        
Legal settlement
                2,500        
 
   
 
     
 
     
 
     
 
 
Total operating expenses
    116,820       100,953       220,680       200,590  
 
   
 
     
 
     
 
     
 
 
Operating income
    52,860       4,369       73,605       14,546  
Interest income
    2,733       5,905       5,233       12,086  
Other income (loss), net
    163       (368 )     412       (897 )
 
   
 
     
 
     
 
     
 
 
Interest and other income (loss), net
    2,896       5,537       5,645       11,189  
 
   
 
     
 
     
 
     
 
 
Income before income taxes
    55,756       9,906       79,250       25,735  
Provision for income taxes
    17,945       2,476       24,758       6,433  
 
   
 
     
 
     
 
     
 
 
Net income
  $ 37,811     $ 7,430     $ 54,492     $ 19,302  
 
   
 
     
 
     
 
     
 
 
Net income per share:
                               
Basic net income per share
  $ 0.25     $ 0.05     $ 0.36     $ 0.13  
 
   
 
     
 
     
 
     
 
 
Diluted net income per share
  $ 0.25     $ 0.05     $ 0.35     $ 0.13  
 
   
 
     
 
     
 
     
 
 
Shares used in basic per share calculation
    149,112       149,950       151,012       149,692  
 
   
 
     
 
     
 
     
 
 
Shares used in diluted per share calculation
    151,386       153,034       153,743       152,631  
 
   
 
     
 
     
 
     
 
 

See accompanying notes to condensed consolidated financial statements.

3


Table of Contents

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)
                 
    June 26,   December 31,
    2004
  2003 *
    (unaudited)        
ASSETS
               
Current assets:
               
Cash and cash equivalents
  $ 314,415     $ 497,178  
Short-term investments
    564,030       504,954  
Accounts receivable, net
    330,190       231,760  
Inventories
    220,747       199,100  
Deferred tax assets, net
    145,889       126,901  
Prepaid and other current assets
    14,744       12,095  
 
   
 
     
 
 
Total current assets
    1,590,015       1,571,988  
Property and equipment, net
    479,592       506,567  
Goodwill
    173,267       173,267  
Intangible and other assets
    95,590       87,078  
 
   
 
     
 
 
Total assets
  $ 2,338,464     $ 2,338,900  
 
   
 
     
 
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
  $ 72,455     $ 53,537  
Accrued payroll and related expenses
    40,842       25,197  
Accrued warranty
    38,264       28,805  
Other accrued liabilities
    47,093       43,406  
Income taxes payable
    39,078       10,293  
Deferred profit
    84,238       46,821  
Current obligations under lines of credit
    8,056       13,023  
 
   
 
     
 
 
Total current liabilities
    330,026       221,082  
Other liabilities
    42,304       45,958  
 
   
 
     
 
 
Total liabilities
    372,330       267,040  
Shareholders’ equity:
               
Common stock
    1,527,955       1,565,926  
Retained earnings
    435,232       501,362  
Accumulated other comprehensive income
    2,947       4,572  
 
   
 
     
 
 
Total shareholders’ equity
    1,966,134       2,071,860  
 
   
 
     
 
 
Total liabilities and shareholders’ equity
  $ 2,338,464     $ 2,338,900  
 
   
 
     
 
 

*   Amounts as of December 31, 2003 are derived from the December 31, 2003 audited financial statements.

See accompanying notes to condensed consolidated financial statements.

4


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)
(unaudited)
                 
    Six Months Ended
    June 26,   June 28,
    2004
  2003
Cash flows from operating activities:
               
Net income
  $ 54,492     $ 19,302  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Gain on sale of an investment
    (365 )      
Loss on extinguishment of debt
          616  
Depreciation and amortization
    41,694       25,716  
Deferred income taxes
    (18,630 )     1,284  
Stock-based compensation
    1,979       2,334  
Income tax benefits from employee stock option plans
          8,870  
Changes in operating assets and liabilities:
               
Accounts receivable
    (98,430 )     (20,353 )
Inventories
    (31,852 )     14,859  
Prepaid and other current assets
    (2,204 )     13,292  
Accounts payable
    18,894       (15,726 )
Accrued payroll and related expenses
    19,467       (6,787 )
Accrued warranty
    9,459       (2,631 )
Other accrued liabilities
    (298 )     (11,936 )
Income taxes payable
    28,785       (8,126 )
Deferred profit
    37,416       (594 )
 
   
 
     
 
 
Net cash provided by operating activities
    60,407       20,120  
 
   
 
     
 
 
Cash flows from investing activities:
               
Proceeds from sales and maturities of short-term investments
    597,504       659,484  
Purchases of short-term investments
    (656,215 )     (676,998 )
Capital expenditures
    (11,438 )     (17,528 )
Decrease (increase) in other assets
    (3,661 )     10,743  
 
   
 
     
 
 
Net cash used in investing activities
    (73,810 )     (24,299 )
 
   
 
     
 
 
Cash flows from financing activities:
               
Repayments of convertible subordinated notes
          (117,053 )
Proceeds from employee stock compensation plans
    17,977       35,260  
Payments on lines of credit, net
    (4,967 )      
Repurchase of common stock
    (182,370 )     (39 )
 
   
 
     
 
 
Net cash used in financing activities
    (169,360 )     (81,832 )
 
   
 
     
 
 
Net decrease in cash and cash equivalents
    (182,763 )     (86,011 )
Cash and cash equivalents at the beginning of the period
    497,178       615,844  
 
   
 
     
 
 
Cash and cash equivalents at the end of the period
  $ 314,415     $ 529,833  
 
   
 
     
 
 

See accompanying notes to condensed consolidated financial statements.

5


Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. BASIS OF PRESENTATION AND STOCK-BASED COMPENSATION

Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to the Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. The interim financial information is unaudited and does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 26, 2004 are not necessarily indicative of the results that may be expected for the year ending December 31, 2004. For further information, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2003.

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the related disclosures of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to revenue recognition, allowance for doubtful accounts, inventory valuation, deferred tax assets, property and equipment, goodwill and other intangible assets, warranty obligations, restructuring and impairment charges, contingencies and litigation, and stock-based compensation. We base our estimates on historical experience and on other assumptions that are believed to be reasonable under the current circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Our intent is to accurately state our assets given facts known at the time of valuation. Our assumptions may prove incorrect as facts change in the future. Actual results may differ from these estimates under different assumptions or conditions.

The accompanying condensed consolidated financial statements include our accounts and the accounts of our wholly-owned subsidiaries after the elimination of all significant intercompany account balances and transactions.

We operate primarily in one segment, the manufacturing, marketing, and servicing of semiconductor wafer fabrication equipment. Since we operate in one segment, all segment-related financial information required by Statement of Financial Accounting Standards (SFAS) No. 131, “Disclosures About Segments of an Enterprise and Related Information,” or SFAS No. 131, is included in the condensed consolidated financial statements.

Stock-Based Compensation

We account for stock-based employee compensation using the intrinsic value method under Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees,” and have adopted the disclosure-only provisions of SFAS No. 123, “Accounting for Stock-Based Compensation,” as amended by SFAS No. 148, “Accounting for Stock-Based Compensation – Transition and Disclosures.” Accordingly, no expense has been recognized for options granted to employees at current market value. We recognize stock-based compensation on the graded vesting method over the vesting periods of the applicable stock purchase rights and stock options, generally four years. The graded vesting method provides for vesting of portions of the overall awards at interim dates and results in greater expense recorded in earlier years than the straight-line method.

SFAS No. 123 requires the use of option pricing models that were not developed for use in valuing employee stock options. The Black-Scholes option-pricing model was developed for use in estimating the fair value of short-lived exchange-traded options that have no vesting restrictions and are fully transferable. In addition, option-pricing models require the input of highly subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. Because the Company’s employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in the opinion of management, the existing models do not necessarily provide a reliable single measure of the fair value of employee stock options.

Had compensation expense been determined based on the fair value at the grant date for awards, consistent with the provisions of SFAS No. 123, we would have reported pro forma net income (loss) and net income (loss) per share as follows (in thousands, except per share data):

6


Table of Contents

                                 
    Three Months Ended
  Six Months Ended
    June 26,   June 28,   June 26,   June 28,
    2004
  2003
  2004
  2003
Net income as reported
  $ 37,811     $ 7,430     $ 54,492     $ 19,302  
Add:
                               
Intrinsic value method expense included in reported net income, net of related tax effects
    1,001       938       1,979       1,422  
Less:
                               
Fair value method expense, net of related tax effects
    (14,028 )     (17,520 )     (27,831 )     (34,462 )
 
   
 
     
 
     
 
     
 
 
Pro-forma net income (loss)
  $ 24,784     $ (9,152 )   $ 28,640     $ (13,738 )
 
   
 
     
 
     
 
     
 
 
Pro-forma basic and diluted net income (loss) per share
  $ 0.17     $ (0.06 )   $ 0.19     $ (0.09 )
 
   
 
     
 
     
 
     
 
 
Basic net income per share as reported
  $ 0.25     $ 0.05     $ 0.36     $ 0.13  
 
   
 
     
 
     
 
     
 
 
Diluted net income per share as reported
  $ 0.25     $ 0.05     $ 0.35     $ 0.13  
 
   
 
     
 
     
 
     
 
 

The fair value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model, with the following weighted-average assumptions for grants made in the three and six months ended June 26, 2004 and June 28, 2003:

                 
    Three Months Ended
  Six Months Ended
    June 26,   June 28,   June 26,   June 28,
    2004
  2003
  2004
  2003
Dividend yield
  None   None   None   None
Expected volatility
  76%   82%   76%   82%
Risk free interest rate
  2.5%   2.5%   2.5%   2.5%
Expected lives
  3.5 years   3.6 years   3.5 years   3.6 years

The weighted-average fair value of stock options granted during the period was $16.38 and $16.77 for the three and six months ended June 26, 2004, respectively, and $14.39 and $15.74 for the three and six months ended June 28, 2003, respectively.

The pro forma net income (loss) and net income (loss) per share data listed above include expense related to the Employee Stock Purchase Plan, referred to herein as the Purchase Plan. The fair value of issuances under the Purchase Plan is estimated on the date of issuance using the Black-Scholes option-pricing model, with the following weighted-average assumptions:

                 
    Three Months Ended
  Six Months Ended
    June 26,   June 28,   June 26,   June 28,
    2004
  2003
  2004
  2003
Dividend yield
  None   None   None   None
Expected volatility
  45%   50%   45%   50%
Risk free interest rate
  1.3%   1.2%   1.3%   1.2%
Expected lives
  .5 year   .5 year   .5 year   .5 year

The weighted-average fair value of purchase rights was $7.92 and $8.78 for the three and six months ended June 26, 2004, respectively, and $6.82 and $8.71 for the three and six months ended June 28, 2003, respectively.

2. ASSET PURCHASE TRANSACTION

In April 2004, we acquired Angstron Systems, Inc. (“Angstron”), a developer of atomic layer deposition technology for advanced semiconductor manufacturing for total consideration of approximately $9.8 million, including transaction costs of approximately $0.3 million. We evaluated the business combination criteria within Statement of Financial Accounting Standards (SFAS) No. 141, “Business Combinations” and, after consideration of these criteria and the criteria included within Emerging Issues Task Force (EITF) No. 98-3 “Determining Whether a Nonmonetary Transaction Involves Receipt of Productive Assets or of a Business”, determined that the purchase of Angstron represented a purchase of assets rather than a business combination, and accordingly, the tangible assets acquired and liabilities assumed were recorded at their estimated fair values at the date of acquisition. The intangible assets acquired were valued by us with the assistance of a third-party appraiser under the provisions of SFAS No. 142, “Goodwill and Other

7


Table of Contents

Intangible Assets.” A portion of the purchase price has been allocated to existing technology and acquired in-process research and development (“IPR&D”). The assets were identified and valued through analysis of data provided to a third-party appraiser concerning developmental products, their stage of development, the time and resources needed to complete them, their expected income generating ability, target markets and associated risks.

Those developmental projects that had not reached technological feasibility and had no alternative future use were classified as IPR&D and expensed in the second quarter of fiscal 2004. The nature of the efforts required to develop the IPR&D into commercially viable products principally relates to the completion of all planning, designing, prototyping, verification and testing activities that are necessary to establish that the products can be produced to meet their design specifications, including functions, features and technical performance requirements.

The purchase price was allocated to the fair value of assets acquired and liabilities assumed as follows (in thousands):

         
Cash consideration
  $ 9,500  
Estimated transaction costs
    320  
 
   
 
 
Total purchase price
  $ 9,820  
 
   
 
 
Patents
    4,197  
Acquired in-process research and development (IPR&D)
    6,124  
Deferred tax liability, net
    (267 )
Tangible assets acquired
    265  
Liabilities assumed
    (499 )
 
   
 
 
Total net assets acquired
  $ 9,820  
 
   
 
 

3. NET INCOME PER SHARE

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. For purposes of computing basic net income per share, the weighted-average number of outstanding shares of common stock excludes shares of restricted stock subject to repurchase.

Diluted net income per share is computed using the weighted-average number of shares of common stock outstanding, including shares of restricted common stock subject to repurchase and, when dilutive, potential shares from stock options to purchase common stock using the treasury stock method.

The following table provides a reconciliation of the numerators and denominators of the basic and diluted per share computations (in thousands, except for per share amounts):

                                 
    Three Months Ended
  Six Months Ended
    June 26,   June 28,   June 26,   June 28,
    2004
  2003
  2004
  2003
Numerator:
                               
Net income
  $ 37,811     $ 7,430     $ 54,492     $ 19,302  
 
   
 
     
 
     
 
     
 
 
Denominator:
                               
Basic weighted-average shares outstanding
    149,112       149,950       151,012       149,692  
Employee stock options and restricted stock
    2,274       3,084       2,731       2,939  
 
   
 
     
 
     
 
     
 
 
Diluted weighted-average shares outstanding
    151,386       153,034       153,743       152,631  
 
   
 
     
 
     
 
     
 
 
Basic net income per share
  $ 0.25     $ 0.05     $ 0.36     $ 0.13  
 
   
 
     
 
     
 
     
 
 
Diluted net income per share
  $ 0.25     $ 0.05     $ 0.35     $ 0.13  
 
   
 
     
 
     
 
     
 
 

Options to purchase approximately 12.3 million and 9.3 million shares of common stock at a weighted-average exercise price of $41.14 and $43.02 per share were outstanding as of June 26, 2004 and June 28, 2003, respectively, but were not included in the computation of diluted net income per common share because the respective exercise prices of these options were greater than the average respective market prices of the common shares and, therefore, the effect would be anti-dilutive.

8


Table of Contents

4. INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out) or market. As of the balance sheet date, inventories consisted of the following (in thousands):

                 
    June 26,   December 31,
    2004
  2003
Purchased and spare parts
  $ 161,723     $ 146,399  
Work-in-process
    50,578       37,502  
Finished goods
    8,446       15,199  
 
   
 
     
 
 
Total inventories
  $ 220,747     $ 199,100  
 
   
 
     
 
 

5. GOODWILL AND INTANGIBLE ASSETS

Goodwill

As of June 26, 2004 and December 31, 2003, we had goodwill of approximately $173.3 million. We completed the annual goodwill impairment test in the fourth quarter of 2003 in accordance with our policy. The first step of the test identifies when impairment may have occurred, while the second step of the test measures the amount of the impairment, if any. The results of our impairment tests did not indicate impairment. There have been no significant events or circumstances affecting the valuation of goodwill subsequent to our impairment test performed in the fourth quarter of 2003.

Intangible Assets

The following tables provide details of our acquired intangible assets (in thousands):

                         
            Accumulated    
June 26, 2004
  Gross
  Amortization
  Net
Patents
  $ 15,877     $ (11,897 )   $ 3,980  
Other intangible assets
    18,540       (5,684 )     12,856  
 
   
 
     
 
     
 
 
Total
  $ 34,417     $ (17,581 )   $ 16,836  
 
   
 
     
 
     
 
 
                         
            Accumulated    
December 31, 2003
  Gross
  Amortization
  Net
Patents
  $ 11,680     $ (10,912 )   $ 768  
Other intangible assets
    18,540       (4,231 )     14,309  
 
   
 
     
 
     
 
 
Total
  $ 30,220     $ (15,143 )   $ 15,077  
 
   
 
     
 
     
 
 

Our estimated amortization expense for the identifiable intangible assets for each of the next five fiscal years will be approximately $3.6 million, $3.6 million, $3.6 million, $3.4 million and $0.7 million, respectively. As of June 26, 2004, we have no identifiable intangible assets with indefinite lives.

6. PRODUCT WARRANTY

We record the estimated cost of warranty as a component of cost of sales upon system shipment. The estimated cost is determined by the warranty term as well as the average historical labor and material costs for a specific product. Should actual product failure rates or material usage differ from our estimate, revisions to the estimated warranty liability may be required. We review the actual product failure rates and material usage on a quarterly basis and adjust our warranty liability as necessary. We have adopted the provisions of FIN 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, including Indirect Indebtedness of Others,” which requires changes to the accounting and disclosure of guarantees, including product warranties. Changes in our accrued warranty liability were as follows (in thousands):

9


Table of Contents

                                 
    Three Months Ended
  Six Months Ended
    June 26,   June 28,   June 26,   June 28,
    2004
  2003
  2004
  2003
Balance, beginning of period
  $ 34,050     $ 30,857     $ 28,805     $ 31,002  
Warranties issued
    21,566       11,311       38,200       24,225  
Settlements
    (17,352 )     (13,797 )     (29,937 )     (26,856 )
Changes in liability for pre-existing warranties, including expirations
                1,196        
 
   
 
     
 
     
 
     
 
 
Balance, end of period
  $ 38,264     $ 28,371     $ 38,264     $ 28,371  
 
   
 
     
 
     
 
     
 
 

7. RESTRUCTURING AND OTHER CHARGES

In 2001, we implemented a restructuring plan that was driven by the decline in sales orders due to the contraction of the semiconductor capital equipment market. Additional restructuring reserves recorded in 2002 were primarily related to exiting business activities of SpeedFam-IPEC that were recognized by us as liabilities assumed in the purchase business combination. In the third quarter of 2003, we implemented a restructuring plan to align our cost structure with business conditions.

The following table summarizes restructuring activity for the six months ended June 26, 2004 (in thousands):

                                 
                    Acquisition    
    Facilities
  Severance
  Expense
  Total
Balance at December 31, 2003
  $ 50,513     $ 592     $ 1,115     $ 52,220  
Cash payments
    (2,234 )     (183 )